CELL INTELLIGENCE · 肿瘤细胞治疗研究

结直肠癌中新抗原生成机制及基于新抗原的免疫治疗进展

Mechanism of neoantigen generation and advances in neoantigen-based immunotherapies in colorectal cancer.

肺癌细胞治疗的全球临床试验格局：现状、趋势与科学挑战

The global clinical trial landscape of lung cancer cellular therapy current status trends and scientific challenges.

本研究系统分析了全球肺癌细胞治疗临床试验的现状与趋势，显示其在技术突破、政策支持和资本投入推动下快速发展。然而，肺癌细胞治疗仍面临靶点选择、疗效提升和安全性优化等科学挑战。未来研究应深入探索，以促进临床转化与应用。

mRNA 疫苗在癌症免疫治疗中的应用：实体瘤和血液系统恶性肿瘤的当前进展与展望

mRNA vaccines in cancer immunotherapy: current progress and perspectives in solid tumors and hematologic malignancies.

IL-12 和 GM-CSF 工程化树突状细胞增强肿瘤反应性 T 细胞的富集和选择用于癌症免疫治疗

IL-12 and GM-CSF engineered dendritic cells enhance the enrichment and selection of tumor-reactive T cells for cancer immunotherapy.

结直肠癌的过继性免疫细胞治疗

Adoptive immune cell therapy for colorectal cancer.

肾细胞癌细胞治疗的未来

The future of cellular therapy for the treatment of renal cell carcinoma.

迄今为止，过继性细胞治疗取得较大治疗成功的领域包括 CIK 细胞的辅助给药以及抗 CD70 CAR-T 细胞在转移性肾细胞癌患者中的输注。

改良树突状细胞 T 细胞扩增方案与单细胞多组学通过分析数千个 MAGE-A3 特异性 T 细胞筛选扩增最多且体外有效的克隆型

Modified Dendritic cell-based T-cell expansion protocol and single-cell multi-omics allow for the selection of the most expanded and in vitro-effectiv

胶质瘤免疫治疗的临床与转化进展

Clinical and Translational Advances in Glioma Immunotherapy.

乳腺癌细胞治疗的现状

Current State of Cell Therapies for Breast Cancer.